DAITO PHARMACEUTICAL CO.,LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,490 JPY | -0.44% |
|
+0.04% | +30.71% |
| Apr. 12 | Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 350,000 shares, representing 2.23% for ¥1,000 million. | CI |
| Apr. 12 | Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan. | CI |
| Sales 2024 * | 47.6B 306M | Sales 2025 * | 52.15B 335M | Capitalization | 39.12B 251M |
|---|---|---|---|---|---|
| Net income 2024 * | 3.34B 21.46M | Net income 2025 * | 3.92B 25.21M | EV / Sales 2024 * | 0.91 x |
| Net Debt 2024 * | 3.98B 25.58M | Net Debt 2025 * | 4.56B 29.26M | EV / Sales 2025 * | 0.84 x |
| P/E ratio 2024 * |
11.8
x | P/E ratio 2025 * |
10
x | Employees | 1,011 |
| Yield 2024 * |
2.4% | Yield 2025 * |
2.64% | Free-Float | 80.05% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.44% | ||
| 1 week | +0.04% | ||
| Current month | +6.23% | ||
| 1 month | +7.51% | ||
| 3 months | +28.22% | ||
| 6 months | +34.52% | ||
| Current year | +30.71% |
1 week
2 413.00
2 517.00
1 month
2 258.002 517.00
Current year
1 868.002 517.00
1 year
1 803.002 517.00
3 years
1 803.003 413.64
5 years
1 803.004 145.45
10 years
1 194.214 145.45
| Managers | Title | Age | Since |
|---|---|---|---|
Kiyotaka Kido
PSD | President | - | - |
Eiichi Takada
CTO | Chief Tech/Sci/R&D Officer | - | - |
Masuo Nomura
ADM | Chief Administrative Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yasunobu Otsuga
BRD | Director/Board Member | 73 | 75-02-28 |
Michio Tsuda
BRD | Director/Board Member | 76 | 71-03-31 |
Hitoshi Hori
BRD | Director/Board Member | 70 | 99-01-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.10% | 15 M€ | +5.53% | ||
| 0.01% | 18 M€ | +16.15% | - | |
| 0.01% | 144,586 M€ | +13.76% | ||
| 0.01% | 66,066 M€ | +13.80% | - | |
| 0.01% | 20,721 M€ | +12.65% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 2,490 | -0.44% | 94 200 |
| 24-04-24 | 2,501 | +0.16% | 86,200 |
| 24-04-23 | 2,497 | -0.04% | 69,800 |
| 24-04-22 | 2,498 | +1.42% | 130,700 |
| 24-04-19 | 2,463 | -1.04% | 92,200 |
Delayed Quote Japan Exchange, April 25, 2024 at 02:00 am EDT
More quotes
Daito Pharmaceutical Co., Ltd. is a Japan-based company mainly engaged in the pharmaceutical ingredients and formulation business, as well as healthy food. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.
Sector
Pharmaceuticals
Calendar
2024-05-29
- Final dividend
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,501
JPY
Average target price
3,155
JPY
Spread / Average Target
+26.15%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +30.71% | 252M | |
| +19.65% | 42.78B | |
| +18.59% | 22.25B | |
| +13.12% | 14.39B | |
| +12.26% | 13.55B | |
| +35.75% | 11.27B | |
| -9.80% | 6.95B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.29% | 5.01B |
- Stock Market
- Equities
- 4577 Stock
